Cong Claire Xu Sells $2.59K of NovaBridge Biosciences (NBP) — SEC Form 4, Sep 01, 2026
Open-Market Net Sale · SEC Form 4
−$2,593
Equity position changed by +2.0%
Equity Position
307K sh
301,383 → 307,483
Equity Change
+2.0%
shares held after vs before
Filing Lag
1 business day
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Cong Claire Xu CIK 0002114309 |
EVP
|
Cong Claire Xu at NovaBridge Biosciences
Full insider history
Bought (12 mo)
—
Sold (12 mo)
$20,351
More from this insider at NovaBridge Biosciences
| 2026-07-07 | Sell | -$3,992 | View |
| 2026-06-02 | Sell | -$13,766 | View |
Non-Derivative Securities Transactions
Derivative Securities Transactions
Footnotes (9)
- F1
- The Ordinary Shares may be represented by American Depositary Shares ("ADS"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer. Show more
- F2
- Reported securities are represented by 4,079 ADSs. Show more
- F3
- Each restricted stock unit ("RSU") represents a contingent right to receive one ADS. Show more
- F4
- Reported securities are represented by 133,688 ADSs. Show more
- F5
- Reported securities are represented by 1,427 ADSs. Show more
- F6
- Reported sales price represents the converted sales price of the ADSs of $1.8186. Show more
- F7
- Reported securities are represented by 132,261 ADSs. Show more
- F8
- Reported securities represent ADSs. Show more
- F9
- On May 30, 2024, the Reporting Person was granted 65,270 RSUs. The RSUs vested or shall vest over four years, with one-fourth vesting on the first anniversary of the grant date and the balance vesting ratably over the subsequent 12 quarters on the 30th day of each third month. Show more
Related filings at NovaBridge Biosciences
Institutional Holders
13F holders · Sep 30, 2026
47
institutional managers reporting a position
Largest by reported value
- Hhlr Advisors, Ltd. $8.16M
- Morgan Stanley $4.74M
- Aihc Capital Management Ltd $3.93M
5%+ Holders · 13D/G
3 filers
-
Hhlr Advisors, Ltd. 4.9%
Other insiders at NovaBridge Biosciences
GET /v1/forms/4/0002114309-26-000007
API docs
View Original SEC Filing